Search

On inventive Californians, technology transfer, how to approach the business press, and other insights into R&D management.

With the US in regulatory limbo, Europe is winning the race to be the first regulated drugs market to approve generic copies of biotech drugs - despite the protests of the biotech pioneers who created them.

A new Swedish company backed by government and business angels aims to create an entire funding ecosystem for young companies until they become ready for venture capital.

Microsoft is to open more research centres in Europe, in a move to step up its research collaboration and boost students' interest in the technology field.

On the glut of patenting, BASF's rising research budget, football fever in the Commons, and other insights into R&D management

Some strange new ways of raising money are starting to emerge - but would-be borrowers and lenders are still making sense of them.

Better, brighter, faster – that's where photonic lasers are trying to take us. A lay guide to the technology.

With licensing and collaboration now the lifeblood of the drug industry, the annual BIO-Europe get-together was focused on partnering. Nuala Moran was there.

Scientists are moving around as never before. And, argues Jean Guinet from the OECD, that’s not necessarily a bad thing.

A new proposal from the European Investment Fund seeks to accelerate the success of European technology transfer projects. A noble idea, says Mary Lisbeth D'Amico in her fortnightly column, but no one has yet stepped up to foot the bill.

It has been six years since a French biotech company made a stock market debut – and now two, BioAlliance and ExonHit, are doing so. Is the European market reawakening?

Britain's privatised defence lab ties up with 7 universities, in a strategy to do more with fewer partners.

Nanonucleant, a spin-out of Imperial College London, is seeking angel financing to move ahead with a glass grain-based technology that aids in crystallising proteins for study as drug targets.

Reports of incubators' demise were premature

For her latest fortnightly funding column, Mary Lisbeth D'Amico set out to find European seed funders. That was as easy as finding a needle in a haystack.

The universities of Cambridge and Manchester, Imperial College London and the SETsquared Partnership, a joint venture among four universities in southern England, have won funding to collaborate with peers in the US and with companies such as Airbus and Boeing.

If you want to lead innovation in R&D, don’t neglect the crucial human factor, says Georges Haour from the IMD in Lausanne, Switzerland.

How to manage a virtual R&D team, valuing research – and other insights into R&D management.